Clinical Trials Browser

Osteosarcoma × camrelizumab × Clear all

NCT06074692 2023-10-31

PRIMA

Phase 2 Recruiting

Sarcoma, Osteosarcoma

NCT04351308 2020-05-19

MAPAC

Phase 2 Unknown

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT04294511 2020-03-04

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

Phase 2 Unknown

Osteosarcoma